Clinical Trials
205 trialsDecisional Regret in Open Partial Horizontal Laryngectomy
IRCCS Azienda Ospedaliero-Universitaria di Bologna
TACO
Centre Leon Berard
Identification of Pattern and Factors Affecting Recurrence in Head and Neck Carcinoma
Sohag University
Real-time Detection of ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck Squamous Cell Carcinoma
University Health Network, Toronto
Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors
TJ Biopharma Co., Ltd.
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
SOTO: Treatment Sensitivity of Organoids to Predict Treatment Outcome
Guy's and St Thomas' NHS Foundation Trust
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
R-Pharm
COMRAD-HNSCC
Institute of Oncology Ljubljana
HYDRA
Erasmus Medical Center
Efficacy and Safety of TORS for SCCA
University of Virginia
HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor
HRYZ Biotech Co.
Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcinoma
Tongji Hospital
A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC
ISA Pharmaceuticals
Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer
National Cancer Centre, Singapore
A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC
ISA Pharmaceuticals
Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
CZCNRHNSCC
Sun Yat-sen University
Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell Carcinoma
Nanfang Hospital, Southern Medical University
A New Mutational and Epigenetic Signature to Predict Early OPSCC Relapse
Centro di Riferimento Oncologico - Aviano
V-CHANCE
National Cancer Institute, Naples
B2023-153
Sun Yat-sen University
UPSTREAM
European Organisation for Research and Treatment of Cancer - EORTC
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
Efficacy and Safety of Netupitant and Palonosetron Hydrochloride Capsules in Preventing Nausea and Vomiting Induced by Radiochemotherapy in Head and Neck Squamous Cell Carcinoma
Sichuan Cancer Hospital and Research Institute
UPLIFT
Massachusetts General Hospital
Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC
First Affiliated Hospital of Zhejiang University
Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer?
Luzerner Kantonsspital
Study of HLA-DR in Cell Cultures Isolated From Primary Squamous Cell Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
InGReS
Guy's and St Thomas' NHS Foundation Trust
NCCCNRHNSCC
Sun Yat-sen University
Sodium Selenite Supplementation in Patients With Head and Neck Cancer
Chang Gung Memorial Hospital
PRO-IMMUNO
University Medical Center Groningen
Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Real-world Analysis on the Efficacy and Safety of Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma （neoHNSCC）
Second Affiliated Hospital, School of Medicine, Zhejiang University
Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma
Maastricht University Medical Center
iCHRTL
Maria Sklodowska-Curie National Research Institute of Oncology
Differential Mobility Spectrometry (DMS) Based Oral Tumor Analysis
Tampere University Hospital
Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors
Shanghai Henlius Biotech
A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Temporal Diffusion Spectroscopy MRI in Predicting the CPS of PD-L1 Expression and the Efficacy of Neoadjuvant Therapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma
Second Affiliated Hospital of Guangzhou Medical University
WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA
Armed Forces Institute of Pathology Rawalpindi
SPOKE
University Medical Center Groningen
Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.
Assiut University
MRI - Guided Adaptive RadioTHerapy for Dysphagia in Head and Neck Cancer
Sichuan Cancer Hospital and Research Institute
The Effect of Nitozumab in the Treatment of Head and Neck Squamous Cell Carcinoma
Sichuan Cancer Hospital and Research Institute
PRINCESS
Fondazione del Piemonte per l'Oncologia
KOHACIN
Technical University of Munich
Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy
Peking Union Medical College Hospital